Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | Healthcare | 422,193.0 | $56.9M | 7.91% | -118K | -21.8% | $134.85 | -15.7% |
| 2 | NUVL | NUVALENT INC | Healthcare | 311,430.0 | $31.3M | 4.35% | -61K | -16.4% | $100.59 | +0.6% |
| 3 | GUTS | FRACTYL HEALTH INC | Healthcare | 9,840,041.0 | $21.6M | 3.01% | -760K | -7.2% | $2.20 | -62.3% |
| 4 | CGON | CG ONCOLOGY INC | Healthcare | 361,158.0 | $15.0M | 2.08% | -277K | -43.4% | $41.52 | +56.9% |
| 5 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 135,950.0 | $14.6M | 2.02% | -234K | -63.3% | $107.04 | -14.8% |
| 6 | BIIB | BIOGEN INC | Healthcare | 75,412.0 | $13.3M | 1.84% | -5K | -6.2% | $175.99 | +8.1% |
| 7 | INSM | INSMED INC | Healthcare | 71,256.0 | $12.4M | 1.72% | -135K | -65.5% | $174.04 | -39.7% |
| 8 | — | ASCENDIS PHARMA A/S | — | 49,228.0 | $10.5M | 1.46% | -4K | -8.1% | $213.24 | — |
| 9 | — | AVALO THERAPEUTICS INC | — | 524,436.0 | $9.5M | 1.32% | -196K | -27.2% | $18.16 | — |
| 10 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 1,116,604.0 | $9.1M | 1.27% | -832K | -42.7% | $8.18 | -0.0% |
| 11 | PCVX | VAXCYTE INC | Healthcare | 148,787.0 | $6.9M | 0.95% | -166K | -52.7% | $46.14 | +12.0% |
| 12 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 541,240.0 | $6.8M | 0.94% | -48K | -8.1% | $12.52 | +14.0% |
| 13 | GOSS | GOSSAMER BIO INC | Healthcare | 2,135,722.0 | $6.6M | 0.92% | -2.6M | -55.3% | $3.10 | -92.5% |
| 14 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 617,608.0 | $6.1M | 0.85% | -161K | -20.7% | $9.93 | -48.8% |
| 15 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 506,242.0 | $6.1M | 0.85% | -194K | -27.7% | $12.08 | +9.3% |
| 16 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 1,051,343.0 | $5.6M | 0.78% | -1.8M | -62.9% | $5.37 | -64.7% |
| 17 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 191,074.0 | $5.2M | 0.72% | -158K | -45.2% | $27.16 | +13.9% |
| 18 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 206,280.0 | $5.2M | 0.72% | -727K | -77.9% | $25.00 | -45.8% |
| 19 | ERAS | ERASCA INC | Healthcare | 1,317,584.0 | $4.9M | 0.68% | -50K | -3.7% | $3.72 | +176.1% |
| 20 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 303,939.0 | $4.0M | 0.55% | -3K | -1.0% | $13.12 | -62.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%